++
+++
Essentials of Diagnosis
++
Irregular enlargement of the uterus (may be asymptomatic)
Heavy or irregular uterine bleeding
Pelvic pain, dysmenorrhea, and pressure
+++
General Considerations
++
Uterine leiomyoma is the most common benign neoplasm of the female genital tract
It is a discrete, round, firm, often multiple uterine tumor composed of smooth muscle and connective tissue
The most convenient classification is by anatomic location
Submucous myomas may become pedunculated and descend through the cervix into the vagina
++
Frequently asymptomatic in nonpregnant women
Abnormal uterine bleeding and pelvic pain or pressure most common symptoms
Occasionally, degeneration occurs, causing intense pain
The risk of miscarriage is increased if the myoma significantly distorts the uterine cavity and interferes with implantation
Fibroids rarely cause infertility by leading to bilateral tubal blockage; they more commonly cause miscarriage and pregnancy complications, such as preterm labor, preterm delivery, and malpresentation
+++
Differential Diagnosis
++
Pregnancy
Adenomyosis
Ovarian tumors
Leiomyosarcoma
++
++
+++
Diagnostic Procedures
++
++
Emergency surgery may be required for acute torsion of a pedunculated myoma
If the patient is markedly anemic as a result of long, heavy menstrual periods, preoperative treatment with following medications will slow or stop bleeding
DMPA, 150 mg intramuscularly every 3 months
Depot leuprolide, 3.75 mg intramuscularly monthly
Nafarelin, 0.2–0.4 mg intranasally twice daily
Then, anemia can be treated before surgery
Levonorgestrel-containing IUDs have also been used to decrease the bleeding associated with fibroids; however, IUD cannot be used with a distorted cavity
The only emergency indication for myomectomy during pregnancy is torsion of a pedunculated fibroid
++
Women who have small asymptomatic myomas can be managed expectantly and evaluated annually
In patients wishing to defer surgical management, nonhormonal therapies (such as NSAIDs and tranexamic acid) have been shown to decrease menstrual blood loss
Hormonal therapies such as GnRH agonists and selective progesterone receptor modulators (SPRMs), ...